Basilea Pharmaceutica Ltd (XSWX:BSLN)
CHF 43.9 -0.25 (-0.57%) Market Cap: 526.94 Mil Enterprise Value: 595.65 Mil PE Ratio: 69.69 PB Ratio: 0 GF Score: 69/100

Full Year 2023 Basilea Pharmaceutica AG Allschwil Earnings Call Transcript

Feb 13, 2024 / 03:00PM GMT
Release Date Price: CHF36.5 (+8.79%)
Operator

Ladies and gentlemen, welcome to the Basilea Pharmaceutica's full year results 2023 conference call and live webcast. I am Sandra, the chorus call operator. I would like to remind you that all participants will be in listen-only mode, and the conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast. At this time. It's my pleasure to hand over to David Veitch, Chief Executive Officer. Please go ahead, sir.

David Veitch
Basilea Pharmaceutica AG Allschwil - CEO

Thank you, and hello, everyone. I'd like to welcome you to our conference call and webcast reviewing our financial results and key achievements for the full year 2023, as well as highlight our upcoming key milestones. For further detailed information, please see the ad hoc announcement issued this morning and also our full year report. These documents are both available on our website at basilea.com. Also I'D like to mention this call contains forward looking statements. Joining me on our call today are Adesh Kaul, our Chief Financial Officer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot